Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and two related compounds on a spectrum of tumors.
D000230:Adenocarcinoma; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor; D002287:Carcinoma, Krebs 2; D005354:Fibrosarcoma; D005910:Glioma; D006918:Hydroxyurea / Q000494:pharmacology; D007942:Leukemia, Experimental; D008228:Lymphoma, Non-Hodgkin; D008545:Melanoma; D051379:Mice; D009374:Neoplasms, Experimental; D009603:Nitroso Compounds / Q000494:pharmacology*; D012516:Osteosarcoma; D051381:Rats; D012510:Sarcoma 180; D012511:Sarcoma 37; D012513:Sarcoma, Experimental; D014508:Urea / Q000494:pharmacology*; D001749:Urinary Bladder Neoplasms
D009603:Nitroso Compounds; D014508:Urea; D006918:Hydroxyurea